by Dr Ken Gillman | Last updated Apr 25, 2021 | Published on Apr 25, 2021 | Anti-Depressants, Other
by Dr Ken Gillman | Last updated Aug 10, 2020 | Published on Dec 15, 2019 | Other
Search for: PROFESSIONAL PAGES MENU 1. Professional Pages Introduction 2. Parnate: starting and adjusting the dose 3. Advising patients about a low tyramine diet 4. The risk of harm from acute tyramine-induced hypertension 5. MAOI Google Group 6. International...
by Dr Ken Gillman | Last updated Sep 28, 2020 | Published on Aug 24, 2019 | Other
Search for: Professional PagesProfessional Pages Professional Videos International MAOI expert group: Editorial and recommendations Overview: MAOI and TCA interactions Attenuation of the MAOI pressor response by NRIs The risk of harm from acute tyramine-induced...
by Dr Ken Gillman | Last updated Sep 28, 2020 | Published on Aug 23, 2019 | Other
Search for: Professional Pages1. Professional Pages Introduction 2. Parnate: starting and adjusting the dose 3. Advising patients about a low tyramine diet 4. The risk of harm from acute tyramine-induced hypertension 5. MAOI Google Group 6. International Professional...
by Dr Ken Gillman | Last updated Sep 28, 2020 | Published on Feb 26, 2018 | Bias in Science, Other
Bias in Science1. Understanding Science: Science and Scientific Information 2. Medical science publishing: A slow-motion train wreck 3. Guidelines: problems aplenty 4. Lancet ‘21 antidepressants’ meta-analysis 5. Stepped trials: Magnifying methodological muddles — the...
by Dr Ken Gillman | Last updated Nov 20, 2017 | Published on Mar 1, 2017 | Anti-Depressants, Other
Search for: Other Stuff Institutions, religions, Catholics and perversionsMirtazapine, a paradigm of mediocre science in a deficient regulatory environmentUnderstanding Receptor Affinity DataThe Vesicular Monoamine Transporter (VMAT2)Mirtazapine: dubious and...
